We teach your immune system to attack and cure cancer
Founders
Hiring Pitch
Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise.
Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This platform can be used to engineer immune cells to efficiently recognize and kill cancer cells, or to create stem cells that are able to regenerate any tissue.
Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.
Tech Stack
We have built a platform to produce a new type of receptor, the Modular Actuation Receptor Complex or MARC, that mimics the modular architecture of immune receptors. These receptors can be used to reprogram immune cells to recognize cancer antigens and direct an immune response against tumor cells. Compared to CAR-T cells, MARCs have twice the tumor clearing power and avoid causing immune exhaustion to ensure a long lasting response.
The MARC’s unique architecture allows us to link any extracellular cue with the required signalling outputs across different pathways to achieve therapeutic success. Oncology is only the first step; the MARC platform is applicable to autoimmunity, neurology, regenerative medicine and more!
Open Positions at Modulari-T (0 Jobs)
2 filled
